+ Follow ADJUVANT COLON CANCER THERAPY Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 293346
[Title] => Study offers new hope for colon cancer cases
[Summary] => Colon cancer is a leading cause of cancer deaths in both men and women, occurring most frequently in men and women older than 50.
Colon cancer is most common in people who smoke, eat a high-fat diet, and have a family history of colorectal cancer. However, majority of colon cancers occur in people older than 50 with no known risk factors other than age.
[DatePublished] => 2005-08-25 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[1] => Array
(
[ArticleID] => 275629
[Title] => Adjuvant treatment for colon cancer OK’d
[Summary] => European authorities recently approved capecitabine, an innovative oral chemotherapy, as an adjuvant treatment (post-surgery) for colon cancer.
The drug has been shown to prolong cancer-free survival with less serious side effects compared to standard current treatment.
Adjuvant chemotherapy is a standard treatment approach for stage III colon cancer to destroy cancer cells remaining in the body after the tumor has been surgically removed.
[DatePublished] => 2005-04-28 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
ADJUVANT COLON CANCER THERAPY
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 293346
[Title] => Study offers new hope for colon cancer cases
[Summary] => Colon cancer is a leading cause of cancer deaths in both men and women, occurring most frequently in men and women older than 50.
Colon cancer is most common in people who smoke, eat a high-fat diet, and have a family history of colorectal cancer. However, majority of colon cancers occur in people older than 50 with no known risk factors other than age.
[DatePublished] => 2005-08-25 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[1] => Array
(
[ArticleID] => 275629
[Title] => Adjuvant treatment for colon cancer OK’d
[Summary] => European authorities recently approved capecitabine, an innovative oral chemotherapy, as an adjuvant treatment (post-surgery) for colon cancer.
The drug has been shown to prolong cancer-free survival with less serious side effects compared to standard current treatment.
Adjuvant chemotherapy is a standard treatment approach for stage III colon cancer to destroy cancer cells remaining in the body after the tumor has been surgically removed.
[DatePublished] => 2005-04-28 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
abtest
August 25, 2005 - 12:00am
